US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US20070122465A1
(en)
*
|
1993-02-22 |
2007-05-31 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
DE69633222T2
(de)
|
1995-02-24 |
2005-09-08 |
Elan Pharma International Ltd. |
Nanopartikel-dispersionen enthaltende aerosole
|
US5747001A
(en)
*
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
DE19537027A1
(de)
|
1995-10-05 |
1997-04-10 |
Beiersdorf Ag |
Hautpflegemittel für alte Haut
|
CA2247270A1
(en)
*
|
1996-02-26 |
1997-08-28 |
Daiichi Pharmaceutical Co., Ltd. |
Liposome and liposome dispersion
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20020155151A1
(en)
*
|
1997-02-11 |
2002-10-24 |
Franz Enzmann |
Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
IT1296914B1
(it)
|
1997-12-01 |
1999-08-03 |
Maria Rosa Gasco |
Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
DE19856432A1
(de)
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
US6200550B1
(en)
*
|
1998-12-11 |
2001-03-13 |
Q-Pharma, Inc. |
Oral care compositions comprising coenzyme Q10
|
DE19905879A1
(de)
*
|
1999-02-11 |
2000-08-17 |
Mse Pharmazeutika Gmbh |
Ubichinon Qn zur Behandlung von Schmerzen
|
US20040034107A1
(en)
*
|
1999-02-11 |
2004-02-19 |
Mse Pharmazeutika Gmbh |
Ubiquinone Qn for the treatment of pain
|
DE19905880A1
(de)
*
|
1999-02-11 |
2000-08-17 |
Mse Pharmazeutika Gmbh |
Spray enthaltend Ubichinon Qn
|
US6616942B1
(en)
*
|
1999-03-29 |
2003-09-09 |
Soft Gel Technologies, Inc. |
Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
|
DE19926156A1
(de)
*
|
1999-06-09 |
2000-12-14 |
Beiersdorf Ag |
Haarkosmetische Zubereitungen insbesondere solche zur Verbesserung der Kämmbarkeit der Haare auf der Grundlage von Ubichinonen
|
DE19926168A1
(de)
*
|
1999-06-09 |
2000-12-14 |
Beiersdorf Ag |
Stylingmittel auf Alkoholbasis mit Biochinonen
|
US6555139B2
(en)
*
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
DE10046541A1
(de)
|
2000-09-19 |
2002-03-28 |
Knoll Ag |
Mechanisch stabile darreichungsformen, enthaltend Ubichinone
|
US6403116B1
(en)
|
2000-11-03 |
2002-06-11 |
Triarco Inductries, Inc. |
Coenzyme Q10 formulation
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
EP1408932A4
(de)
*
|
2001-06-23 |
2009-02-25 |
Lyotropic Therapeutics Inc |
Teilchen mit verbesserter solubilisierungseigenschaft
|
CN1561218A
(zh)
|
2001-07-27 |
2005-01-05 |
努特里奇亚有限公司 |
用于预防和/或治疗败血症的肠道组合物
|
US20080305173A1
(en)
*
|
2001-07-31 |
2008-12-11 |
Beuford Arlie Bogue |
Amorphous drug beads
|
EP1436844B1
(de)
|
2001-09-05 |
2016-03-23 |
Rensselaer Polytechnic Institute |
Passivierte nanopartikel, verfahren zu ihrer herstellung und einrichtungen mit nanopartikeln
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL160570A0
(en)
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
DE10151392A1
(de)
*
|
2001-10-18 |
2003-05-08 |
Bayer Cropscience Ag |
Pulverförmige Feststoff-Formulierungen
|
AU2002343555A1
(en)
*
|
2001-11-14 |
2003-05-26 |
Texas Tech University |
Eutectic-based self-nanoemulsified drug delivery system
|
WO2003043728A1
(en)
*
|
2001-11-22 |
2003-05-30 |
Firmenich Sa |
Perfuming or flavouring microcapsules comprising a fireproofing agent
|
BR0307332A
(pt)
|
2002-02-01 |
2004-12-07 |
Pfizer Prod Inc |
Formas de dosagem farmacêuticas de liberação controlada de um inibidor da proteìna de transferência do éster de colesterol
|
ATE392152T1
(de)
*
|
2002-02-14 |
2008-05-15 |
Dsm Ip Assets Bv |
Coenzym q10 formulierungen
|
AU2003218718A1
(en)
*
|
2002-03-09 |
2003-09-22 |
Mse Pharmazeutika Gmbh |
Utilization of ubiquinones for influencing the effect of histamine
|
DE10214031A1
(de)
*
|
2002-03-27 |
2004-02-19 |
Pharmatech Gmbh |
Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
|
WO2004006959A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd |
Liquid dosage compositions of stable nanoparticulate active agents
|
ITMI20021725A1
(it)
*
|
2002-08-01 |
2002-10-31 |
Zambon Spa |
Composizioni farmaceutiche ad attivita' antibiotica.
|
EP2111856A3
(de)
|
2002-08-12 |
2014-09-10 |
Bend Research, Inc. |
Pharmazeutische Zusammensetzungen von halbgeordneten Arzneimitteln und Polymeren
|
US20050004002A1
(en)
|
2002-12-09 |
2005-01-06 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
EP1587524A4
(de)
*
|
2003-01-09 |
2006-07-26 |
Arizeke Pharmaceuticals Inc |
Zusammensetzungen und verfahren für die gezielte biologische abgabe von molekularen trägern
|
WO2004069138A2
(en)
*
|
2003-02-03 |
2004-08-19 |
Novartis Ag |
Pharmaceutical formulation
|
US20070056465A1
(en)
*
|
2003-03-06 |
2007-03-15 |
Rensselaer Polytechnic Institute |
Rapid generation of nanoparticles from bulk solids at room temperature
|
WO2004080208A1
(ja)
*
|
2003-03-11 |
2004-09-23 |
Kaneka Corporation |
コエンザイムq10を含有した水中油型乳化組成物、及びその製法
|
DE10311352A1
(de)
*
|
2003-03-14 |
2004-09-23 |
Siemens Ag |
Im HE(21 delta)-Mode anregbarer Resonator
|
DE10312763A1
(de)
*
|
2003-03-21 |
2004-09-30 |
IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG |
Verfahren zur Herstellung einer SLN-Dispersion
|
US7438903B2
(en)
|
2003-06-06 |
2008-10-21 |
Nbty, Inc. |
Methods and compositions that enhance bioavailability of coenzyme-Q10
|
CH715855B1
(de)
*
|
2003-08-28 |
2020-08-14 |
Mibelle Ag |
Zubereitung bestehend aus mindestens zwei Nanoemulsionen.
|
US8124072B2
(en)
|
2003-09-29 |
2012-02-28 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
US8105583B2
(en)
*
|
2003-09-29 |
2012-01-31 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
US7713440B2
(en)
*
|
2003-10-08 |
2010-05-11 |
Lyotropic Therapeutics, Inc. |
Stabilized uncoated particles of reversed liquid crystalline phase materials
|
JP5247031B2
(ja)
*
|
2004-01-22 |
2013-07-24 |
ユニバーシティー・オブ・マイアミ |
局所用コエンザイムq10製剤
|
US7354980B1
(en)
|
2004-03-12 |
2008-04-08 |
Key Medical Technologies, Inc. |
High refractive index polymers for ophthalmic applications
|
EP1730516A1
(de)
*
|
2004-03-30 |
2006-12-13 |
Pfizer Products Incorporated |
Verfahren und vorrichtung zur bewertung pharmazeutischer zusammensetzungen
|
US7803366B2
(en)
|
2004-05-07 |
2010-09-28 |
Nbty, Inc. |
Methods and compositions that enhance bioavailability of coenzyme-Q10
|
US7446157B2
(en)
|
2004-12-07 |
2008-11-04 |
Key Medical Technologies, Inc. |
Nanohybrid polymers for ophthalmic applications
|
ES2607454T3
(es)
|
2005-06-03 |
2017-03-31 |
Acrux Dds Pty Ltd |
Método y composición para el suministro transdérmico de testosterona
|
EP1905064A2
(de)
*
|
2005-06-24 |
2008-04-02 |
Applied Nanoworks, Inc. |
Nanopartikel und verfahren zu ihrer herstellung
|
US10532028B2
(en)
*
|
2005-07-28 |
2020-01-14 |
Isp Investments Llc |
Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
|
CN101242809A
(zh)
*
|
2005-08-12 |
2008-08-13 |
阿斯利康(瑞典)有限公司 |
方法
|
WO2008054508A2
(en)
*
|
2006-04-13 |
2008-05-08 |
Alza Corporation |
Stable nanosized amorphous drug
|
US8491888B2
(en)
*
|
2006-05-05 |
2013-07-23 |
Softgel Formulators, Inc. |
Highly absorbable coenzyme Q10 composition and method of producing same
|
WO2008002485A2
(en)
*
|
2006-06-23 |
2008-01-03 |
Alza Corporation |
Increased amorphous stability of poorly water soluble drugs by nanosizing
|
US20080245769A1
(en)
*
|
2006-07-17 |
2008-10-09 |
Applied Nanoworks, Inc. |
Nanoparticles and method of making thereof
|
US20100062073A1
(en)
*
|
2006-11-29 |
2010-03-11 |
Ronald Arthur Beyerinck |
Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
|
WO2008076780A2
(en)
*
|
2006-12-14 |
2008-06-26 |
Isp Investments Inc. |
Amorphous valsartan and the production thereof
|
WO2008080037A2
(en)
*
|
2006-12-21 |
2008-07-03 |
Isp Investments Inc. |
Carotenoids of enhanced bioavailability
|
WO2008092057A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Isp Investments Inc. |
Formulation process method to produce spray dried products
|
WO2008092046A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Isp Investments Inc. |
Amorphous oxcarbazepine and the production thereof
|
WO2008097165A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Astrazeneca Ab |
Process for preparation of a stable dispersion of solid amorphous submicron particles in an aqueous medium
|
TW200848039A
(en)
*
|
2007-02-09 |
2008-12-16 |
Astrazeneca Ab |
Pharmaceutical compositions
|
US8343541B2
(en)
|
2007-03-15 |
2013-01-01 |
Soft Gel Technologies, Inc. |
Ubiquinol and alpha lipoic acid compositions
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
US8309129B2
(en)
*
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
US8703204B2
(en)
*
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8974827B2
(en)
*
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
EP2178518A2
(de)
*
|
2007-07-13 |
2010-04-28 |
Bend Research, Inc |
Nanopartikel mit ionisierbaren und schwach wasserlöslichen zellulose-polymeren
|
KR100790957B1
(ko)
|
2007-09-06 |
2008-01-04 |
영남대학교 산학협력단 |
코-엔자임 q 경구용 고형제제 조성물
|
EP2231169B1
(de)
*
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
EP2240162A4
(de)
*
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
Nanoteilchen mit einem nicht-ionisierbaren polymer und einem amin-funktionalisierten methacrylat-copolymer
|
ES2403193T3
(es)
|
2008-02-05 |
2013-05-16 |
Laboratorios Bago S.A. |
Composiciones que comprenden alprazolam para el tratamiento del insomnio primario y del insomnio asociado con estados de ansiedad y procedimientos para su preparación
|
US20110136231A1
(en)
|
2008-04-11 |
2011-06-09 |
Cytotech Labs, Llc |
Methods and use of inducing apoptosis in cancer cells
|
US20110039109A1
(en)
*
|
2008-04-30 |
2011-02-17 |
Sika Technology Ag |
Activator for epoxy resin compositions
|
CN102014621A
(zh)
*
|
2008-05-09 |
2011-04-13 |
巴斯夫欧洲公司 |
制备以非晶形形式包含农业化学活性成分的颗粒的方法
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
JP2012506904A
(ja)
|
2008-10-28 |
2012-03-22 |
エージェンシー フォー サイエンス,テクノロジー アンド リサーチ |
難水溶性成分のためのメソ多孔性材料賦形剤
|
EP2376068A2
(de)
|
2008-12-15 |
2011-10-19 |
Banner Pharmacaps, Inc. |
Verfahren zur verbesserung der freisetzung und absorption von wasserunl?slichen wirkstoffen
|
KR101066197B1
(ko)
*
|
2009-04-06 |
2011-09-20 |
한국생명공학연구원 |
코엔자임 q10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
|
EP2430455A4
(de)
|
2009-05-11 |
2013-09-04 |
Berg Pharma Llc |
Verfahren zur diagnose von stoffwechselerkrankungen mit epimetabolischen shiftern, mehrdimensionalen intrazellularen molekülen oder umgebungsbeeinflussern
|
US20120087978A1
(en)
|
2009-06-16 |
2012-04-12 |
Bristol-Myers Squibb Company |
Dosage forms of apixaban
|
JP5965319B2
(ja)
|
2009-10-22 |
2016-08-03 |
エイピーアイ・ジェネシス,エルエルシー |
フラボノイド含有組成物の製造方法及び使用
|
PE20130045A1
(es)
|
2010-03-12 |
2013-01-28 |
Berg Pharma Llc |
FORMULACIONES INTRAVENOSAS DE COENZIMA Q10 (CoQ10) Y METODOS DE USO DE LAS MISMAS
|
DE102010021688A1
(de)
*
|
2010-05-27 |
2011-12-01 |
Qineva Gmbh & Co. Kg |
Verfahren zur Herstellung eines micellaren Wirkstoffkonzentrats
|
AU2012240222B2
(en)
|
2011-04-04 |
2017-04-27 |
Berg Llc |
Methods of treating central nervous system tumors
|
EP2510930A1
(de)
|
2011-04-15 |
2012-10-17 |
Bionanoplus, S.L. |
Nanopartikel mit Halbestern aus Poly(Methylvinylether-Co-Maleinsäureanhydrid) und Verwendungen davon
|
CN103732214B
(zh)
|
2011-06-17 |
2017-04-12 |
博格有限责任公司 |
可吸入药物组合物
|
CA2859174C
(en)
|
2011-12-12 |
2019-03-05 |
Orbis Biosciences, Inc. |
Sustained release particle formulations
|
CN105338973A
(zh)
|
2013-04-08 |
2016-02-17 |
博格有限责任公司 |
使用辅酶q10联合疗法治疗癌症
|
SG11201601583TA
(en)
|
2013-09-04 |
2016-04-28 |
Berg Llc |
Methods of treatment of cancer by continuous infusion of coenzyme q10
|
KR101499867B1
(ko)
*
|
2014-04-22 |
2015-03-06 |
에스케이케미칼주식회사 |
활성 성분 (i) 함유 조성물 및 이의 제조 방법
|
EP3103440A1
(de)
*
|
2015-06-12 |
2016-12-14 |
INDENA S.p.A. |
Feste dispersionen von coenzym q10
|
CN111135142A
(zh)
*
|
2020-01-16 |
2020-05-12 |
兰州大学 |
一种异甘草素纳米乳及其制备方法
|